ENTtoday
  • Home
  • COVID-19
  • Practice Focus
    • Allergy
    • Facial Plastic/Reconstructive
    • Head and Neck
    • Laryngology
    • Otology/Neurotology
    • Pediatric
    • Rhinology
    • Sleep Medicine
  • Departments
    • Issue Archive
    • TRIO Best Practices
      • Allergy
      • Facial Plastic/Reconstructive
      • Head and Neck
      • Laryngology
      • Otology/Neurotology
      • Pediatric
      • Rhinology
      • Sleep Medicine
    • Career Development
    • Case of the Month
    • Everyday Ethics
    • Health Policy
    • Legal Matters
    • Letter From the Editor
    • Medical Education
    • Online Exclusives
    • Practice Management
    • Resident Focus
    • Rx: Wellness
    • Special Reports
    • Tech Talk
    • Viewpoint
    • What’s Your O.R. Playlist?
  • Literature Reviews
    • Allergy
    • Facial Plastic/Reconstructive
    • Head and Neck
    • Laryngology
    • Otology/Neurotology
    • Pediatric
    • Rhinology
    • Sleep Medicine
  • Events
    • Featured Events
    • TRIO Meetings
  • Contact Us
    • About Us
    • Editorial Board
    • Triological Society
    • Advertising Staff
    • Subscribe
  • Advertise
    • Place an Ad
    • Classifieds
    • Rate Card
  • Search

Triptans Prove Helpful in Treating ‘Sinus Headaches

by Ed Susman • June 1, 2008

  • Tweet
  • Email
Print-Friendly Version

ORLANDO, FL-Researchers recommended that otolaryngologists might empirically treat selected patients with sinus headaches as if these patients actually had migraines, following study results illustrating that the use of triptans brought relief to more than 80% of these individuals.

You Might Also Like

  • FDA Advisory on Triptans and SSRI/SNRIs Will Not Affect Migraine Treatment, Say Experts
  • Wrong Diagnosis of Sinus Headache Can Lead to Inappropriate Treatment
  • Nonstandard Thinking Required to Meet the Challenge of Complex Sinus Conditions
  • Targeting Headaches: Trigger release surgery an option for patients with chronic migraine
Explore This Issue
June 2008

Our data support the idea that otolaryngologists should consider migraine when we are evaluating sinus headaches, said Elina Kari, MD, a medical house officer in the Department of Otolaryngology at Emory University in Atlanta. She presented her paper at the 111th annual meeting of the Triological Society, held at the Combined Otolaryngology Spring Meeting.

This study demonstrated that the demographics of patients with self-described ‘sinus headaches’ who did not have findings of sinusitis on endoscopy and CT scan closely reflected the demographics of patients afflicted with migraines, Dr. Kari said.

Of the 38 patients who were able to complete the study, 31 achieved a 50% or greater relief in headache symptoms while on triptan drugs. The patients were assigned to take eletriptan 40 mg upon onset of perceived sinus headache pain, and were instructed to repeat the dose within two hours if the headache was not adequately relieved. If eletriptan was ineffective, patients were switched to sumatriptan or rizatriptan. Seven of the 38 patients, in fact, were successfully treated with a trial of these other drugs because of an inadequate response to eletriptan.

Elina Kari, MD

Elina Kari, MD

Dr. Kari said that one additional patient reported between a 25% and 50% reduction in pain symptoms. Another three patients achieved significant reduction in pain relief by following non-triptan migraine-directed therapy with lifestyle or diet changes. Three patients reported no change in symptoms with eletriptan use.

The vast majority of these patients who completed the trial-82 percent-had a significant improvement in pain relief, she said.

Patients eligible for the trial were those who presented to the practice of the senior author, John M. DelGaudio, MD, at a tertiary care otolaryngology department with primary complaints of facial pain, pressure, or headache localized over the area of the sinuses, and a self- or physician diagnosis of sinus headache.

The participants underwent a directed history, physical examination including rigid nasal endoscopy, a sinus computer-assisted tomography (CT) scan, and completed a headache questionnaire. Those patients completed a headache diary for each headache using a visual analog scale to rate the headache before and after triptan use.

Our data support other studies that have looked at this topic, Dr. Kari said, although she noted differences in methodology in the other studies, including the use of a single agent at a single interval.

Implications for Diagnosis and Treatment

There is a tendency among primary care physicians to classify facial pain as a sinus headache. All these patients had negative sinus computed tomography findings, so we know they didn’t have sinusitis, said Harold C. Pillsbury, MD, Professor and Chair of Otolaryngology-Head and Neck Surgery at the University of North Carolina, Chapel Hill. Dr. Pillsbury, President of the Triological Society, was co-moderator of the session at which Dr. Kari presented her report.

Pages: 1 2 3 | Single Page

Filed Under: Departments, Head and Neck, Medical Education, Practice Focus Tagged With: COSM, CT, diagnosis, medication, outcomes, research, sinus headache, Sinusitis, treatmentIssue: June 2008

You Might Also Like:

  • FDA Advisory on Triptans and SSRI/SNRIs Will Not Affect Migraine Treatment, Say Experts
  • Wrong Diagnosis of Sinus Headache Can Lead to Inappropriate Treatment
  • Nonstandard Thinking Required to Meet the Challenge of Complex Sinus Conditions
  • Targeting Headaches: Trigger release surgery an option for patients with chronic migraine

The Triological SocietyENTtoday is a publication of The Triological Society.

The Laryngoscope
Ensure you have all the latest research at your fingertips; Subscribe to The Laryngoscope today!

Laryngoscope Investigative Otolaryngology
Open access journal in otolaryngology – head and neck surgery is currently accepting submissions.

Classifieds

View the classified ads »

TRIO Best Practices

View the TRIO Best Practices »

Top Articles for Residents

  • Do Training Programs Give Otolaryngology Residents the Necessary Tools to Do Productive Research?
  • Why More MDs, Medical Residents Are Choosing to Pursue Additional Academic Degrees
  • What Physicians Need to Know about Investing Before Hiring a Financial Advisor
  • Tips to Help You Regain Your Sense of Self
  • Should USMLE Step 1 Change from Numeric Score to Pass/Fail?
  • Popular this Week
  • Most Popular
  • Most Recent
    • The Dramatic Rise in Tongue Tie and Lip Tie Treatment
    • Vertigo in the Elderly: What Does It Mean?
    • Experts Delve into Treatment Options for Laryngopharyngeal Reflux
    • Some Laryngopharyngeal Reflux Resists PPI Treatment
    • Weaning Patients Off of PPIs
    • Vertigo in the Elderly: What Does It Mean?
    • New Developments in the Management of Eustachian Tube Dysfunction
    • Some Laryngopharyngeal Reflux Resists PPI Treatment
    • Eustachian Tuboplasty: A Potential New Option for Chronic Tube Dysfunction and Patulous Disease
    • The Dramatic Rise in Tongue Tie and Lip Tie Treatment
    • Podcasts Becoming More Popular Method of Education for Otolaryngologists
    • How to Embrace Optimism in the Midst of the COVID-19 Pandemic
    • Tips on How to Approach Conversations with Patients about the COVID-19 Vaccine
    • Steps You Should Take to Protect Your Voice and Hearing During Telemedicine Sessions
    • Routine Postoperative Adjunct Treatments Unnecessary for Idiopathic Cerebrospinal Fluid Leaks

Polls

Have you spoken with your patients about receiving the COVID-19 vaccine?

View Results

Loading ... Loading ...
  • Polls Archive
  • Home
  • Contact Us
  • Advertise
  • Privacy Policy
  • Terms of Use

Visit: The Triological Society • The Laryngoscope • Laryngoscope Investigative Otolaryngology

Wiley
© 2021 The Triological Society. All Rights Reserved.
ISSN 1559-4939

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.